Patents by Inventor Peter Laivins

Peter Laivins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods For Treating Pancreatic Cancer Using Combination Therapies
    Publication number: 20230088999
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Application
    Filed: May 25, 2022
    Publication date: March 23, 2023
    Applicant: Ipsen Biopharm Ltd.
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • Methods for treating pancreatic cancer using combination therapies
    Patent number: 11369597
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Grant
    Filed: June 19, 2018
    Date of Patent: June 28, 2022
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
    Publication number: 20220096458
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Application
    Filed: March 17, 2021
    Publication date: March 31, 2022
    Applicant: Ipsen Biopharm Ltd.
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
    Patent number: 10980795
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Grant
    Filed: June 19, 2018
    Date of Patent: April 20, 2021
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
    Patent number: 10744130
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Grant
    Filed: June 19, 2018
    Date of Patent: August 18, 2020
    Assignee: Ipsen Biopharm Ltd.
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • Methods For Treating Pancreatic Cancer Using Combination Therapies
    Publication number: 20190117644
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Application
    Filed: June 19, 2018
    Publication date: April 25, 2019
    Applicant: Ipsen Biopharm Ltd.
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
    Publication number: 20190117643
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Application
    Filed: June 19, 2018
    Publication date: April 25, 2019
    Applicant: Ipsen Biopharm Ltd.
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • Methods for Treating Pancreatic Cancer Using Combination Therapies
    Publication number: 20180008591
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Application
    Filed: July 31, 2017
    Publication date: January 11, 2018
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN
    Publication number: 20170368056
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Application
    Filed: July 18, 2017
    Publication date: December 28, 2017
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • Methods for treating pancreatic cancer using combination therapies
    Patent number: 9717724
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Grant
    Filed: August 19, 2016
    Date of Patent: August 1, 2017
    Assignee: Ipsen Biopharm Ltd.
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • TREATMENT OF PANCREATIC CANCER WITH LIPOSOMAL IRINOTECAN
    Publication number: 20170202840
    Abstract: A liposome-encapsulated formulation of irinotecan can be used for the treatment of pancreatic cancer in combination with 5-fluorouracil and leucovorin, including treatment of patients diagnosed with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine.
    Type: Application
    Filed: January 11, 2017
    Publication date: July 20, 2017
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN
    Publication number: 20170065578
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Application
    Filed: November 2, 2016
    Publication date: March 9, 2017
    Inventors: Eliel Bayever, NAVREET DHINDSA, JONATHAN BASIL FITZGERALD, PETER LAIVINS, VICTOR MOYO, CLET NIYIKIZA, JAEYEON KIM
  • METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES
    Publication number: 20170049768
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Application
    Filed: November 2, 2016
    Publication date: February 23, 2017
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim, Bambang Adiwijaya
  • Methods for Treating Pancreatic Cancer Using Combination Therapies
    Publication number: 20160375004
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Application
    Filed: August 19, 2016
    Publication date: December 29, 2016
    Inventors: ELIEL BAYEVER, NAVREET DHINDSA, JONATHAN BASIL FITZGERALD, PETER LAIVINS, VICTOR MOYO, CLET NIYIKIZA, JAEYEON KIM
  • Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
    Patent number: 9492442
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Grant
    Filed: September 11, 2015
    Date of Patent: November 15, 2016
    Assignee: Merrimack Pharmaceuticals, Inc.
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
    Patent number: 9452162
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Grant
    Filed: June 12, 2013
    Date of Patent: September 27, 2016
    Assignee: Merrimack Pharmaceuticals, Inc.
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPIES COMPRISING LIPOSOMAL IRINOTECAN
    Publication number: 20160228428
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Application
    Filed: March 3, 2016
    Publication date: August 11, 2016
    Inventors: Eliel Bayever, NAVREET DHINDSA, JONATHAN BASIL FITZGERALD, PETER LAIVINS, VICTOR MOYO, CLET NIYIKIZA
  • Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
    Patent number: 9364473
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Grant
    Filed: September 3, 2015
    Date of Patent: June 14, 2016
    Assignee: Merrimack Pharmaceuticals, Inc.
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
    Patent number: 9339497
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Grant
    Filed: July 29, 2015
    Date of Patent: May 17, 2016
    Assignee: Merrimack Pharmaceuticals, Inc.
    Inventors: Eliel Bayever, Navreet Dhindsa, Jonathan Basil Fitzgerald, Peter Laivins, Victor Moyo, Clet Niyikiza, Jaeyeon Kim
  • Methods for Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan
    Publication number: 20160074382
    Abstract: Provided are methods for treating pancreatic cancer in a patient by administering liposomal irinotecan (MM-398) alone or in combination with additional therapeutic agents. In one embodiment, the liposomal irinotecan (MM-398) is co-administered with 5-fluorouracil and leucovorin.
    Type: Application
    Filed: September 11, 2015
    Publication date: March 17, 2016
    Inventors: ELIEL BAYEVER, NAVREET DHINDSA, JONATHAN BASIL FITZGERALD, PETER LAIVINS, VICTOR MOYO, CLET NIYIKIZA